CTIX Discussion 08/17/2014 21:31:16 $CTIX According to

New Post Public Reply Private Reply Replies (0) Message Board
Jake13
CTIX Discussion 08/17/2014 21:31:16 $CTIX
According to your theory, people expect results in 2 to 3 months? It's already started rising. Go CTIX!
Romad, I'm concerned whenever the law of supply and demand is violated by legalized crooks and legalized practices. Who's fooling who? The MMs and the current practice needs a major facelift. My two big cents... nothing personal to you Romad. I just feel very frustrated when the markets flaws go overlooked and none gives a shit to fix things.
NoRetreat that report slipped my mind. Good call
But the shorts keep the life-blood of the market going. I have never sold anything I haven't owned for at least a year. Since I don't own full percentages of stocks, I am not a big influence on price swings. I believe that with volume comes opportunity. Even if volume is initiated by shorts, a solid investment will keep the longs attracted to it.
Prurisol Phase 1 final report should be available. On August 7 we were informed that the report would be available at the end of last week.

Quote:
The game plan is to receive the final report late next week. Then, select vendors from the bids that were tendered to us (next week). Review the protocol with the sites selected for the trial. Prepare a meeting with the fda for guidance on any questions we may have. (Before each phase, you are allowed one opportunity.) Complete FDA meeting and file protocol for phase 2/3. The longest part will be waiting for FDA meeting, appx 30-60 days. All other steps will go relatively quickly. Realistically a 3-4 month process because we've already done all the prep work.
Leo

Yes for the shorts...not for the longs. When Leo sales, I sale. JMO of course...
Kevetrin attacks cancer from a wide variety of methods

http://cellceutix.com/cellceutix-anti-cancer-...taFH7.dpbs

Good luck and GOD bless,

George
Thank you all who responded to my line of questioning today. Now for the last one:

If we are possibly on the precipice of Brilacidin's coming out party, wouldn't it be logical to think from now until we hear trial results we could expect steady gains along an up and down roller coaster ride? Isn't the motto of the stock market, "buy the rumor, sell the news," and we're entering the "rumor" stage?

I think Friday was the start of a very volatile, but very exciting trek...
Dr. Menon would not risk K,P developing compounds, and co. on a developmentally risky compound as B unless there was great data supporting results! R &R in a few days! Sucks to be selling under $3.
All of that, and the prior B study kinda sucked to be blunt.
From TOB's rally monkey to Wild4's rocket blast off, and BK's bold 6-60 in 2015 I am ready to get the party started.
I truly believe the B trial report equalling Dapto will do just that...lift off
CTIX will likely start rising about 2 to 3 months before the market's expectation of B results. Afterward it will drop or rise afterward depending on the results and how far up it rose prior.
R&R will be the big news release! Only days away!
I don't think we see cohort 8 news for another month. Jmo. It started around Middle of June I thought. 3 months puts us at middle of Sept?

I do think B results if positive will take us into the double digits with a deal. Like BK said...6-60 short term.


R&R conference blockbuster B news only days away! Hold onto you hats!
Yes. I predict we at least get end of cohort 8 news AND 100% Brilla trial enrollment. One Monday and the other Wednesday.

Go CTIX!
Until the weekly macd crosses the zero line I'm not getting too excited (close to 2.00 and even on the year). It has done this only twice over the last 2 1/2 years. The last signal was near 2.00 and it fizzled and fried. The signal prior to that was the explosion from .60, and the rest is history.........................moving forward, the best is yet to come fundamentals and Leo speak, LOL will dominate the headlines.
PR this week..? Anyone?
Thanks. I wasn't clear on the meaning but now I get it.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Haier Biomedical's Strategic Expansion in the U.S.

Updated Category News Views 23

Nailing the U.S. Market with Cold Precision Haier Biomedical isn't just in the game to compete—they're setting the game rules with their mind-boggling expertise in blood management and pharmaceutical storage solutions. This October, they took center stage at the AABB and ISPE 2026 meetings, and they weren't messing around. Fresh Off the Exhibit Floor: Haier's Ambitions...

Continue Reading
Collective Scoops $100M, Powers Solopreneur's Financial Might

Updated Category News Views 0

Picture This: A Solo Businessman in 2026 Imagine a lone ranger running a show that used to take an entire office. That’s the magic happening with roughly 30 million solo businesses in the U.S. today, and folks, the numbers are staggering. As these one-man-bands push past clunky old systems, a big name is lighting the way: Collective. They raised a hefty $100 million to...

Continue Reading
Shield HealthCare Expands Access for Astiva Members

Updated Category News Views 46

Opening Up New Avenues for Health Care Here's a nugget from the healthcare sector that's worth chewing on. Shield HealthCare has just inked a deal with Astiva Health that opens the floodgates for eligible members in Southern California to access medical supplies through Shield's extensive network. It's a big move that aims to make health management a tad easier for folks...

Continue Reading
Luxury Travel Spikes While Budget Trips Take a Hit

Updated Category News Views 73

Luxury Trips on The Uptrend Luxury travel is surging while budget trips are taking a backseat. According to Squaremouth's latest data, high-end getaways insured for a whopping $30,000 or more shot up by 27.2% in the third quarter of 2026 compared to the same time last year. In contrast, budget-friendly jaunts under $10,000 dipped by 2.3%. Travelers seem ready to splurge...

Continue Reading
Hershey's Sweet Results: 2026 Earnings Soar

Updated Category News Views 94

Hershey's 2026 Q3 Financial Performance: A Closer Look At the end of September, The Hershey Company (NYSE: HSY) dished out some eye-popping numbers for their third quarter. With a net sales increase of 3.0%, they clocked in at $3,275.5 million. More importantly, earnings per share-diluted shot up by a whopping 111.8%, landing at $2.88. Clearly, Hershey’s strategic moves...

Continue Reading
BTQ's MIMIQ: A Quantum Leap for 35,000 Developers

Updated Category News Views 24

Breaking Barriers in Quantum Emulation If you think the quantum computing game is all about hardware, then you're missing half the picture. Enter BTQ Technologies, crash-landing into the scene by throwing open the doors of their MIMIQ emulator to a crowd of over 35,000 quantum developers through qBraid. This ain't just an upgrade—it's a seismic shift. More qubits, more...

Continue Reading
HiTHIUM Powers Up Australia's Energy Storage Future

Updated Category News Views 92

Just imagine, folks, a slice of the energy world reshaping right under our feet in good ol' Australia. That's the buzz HiTHIUM sparked at All Energy Australia as they showcased their fancy ?Power 6.9MWh, 8-hour long-duration battery storage system (BESS). It wasn’t just about the tech superiority but the strategic planting of stakes in the local energy market....

Continue Reading
XREAL AURA: A New Era of Wired XR Glasses

Updated Category News Views 72

Pioneering the XR Frontier Welcome to another day under the sun of cutting-edge tech, where XREAL's striking a chord with its new wired XR glasses—AURA. First off, don't let the tangled history of tech hype get to you. In the wild world of extended reality, we've seen plenty of flash, not enough substance. But XREAL's hitting the market with AURA, and I gotta say,...

Continue Reading
Solink Secures $100M: NYSE Sees Tech and Sports Moves

Updated Category News Views 64

Folks, it’s a busy day on Wall Street, with Solink leading the charge by landing over a cool $100 million in fresh funding. Let's break this down because when startups pocket nine-digit figures, it's time to pay attention. Solink's Leap Forward Now, what’s Solink doing with all that cash? They're not scrambling for coffee money, that's for sure. Instead, this funding...

Continue Reading
Circus Circus Vegas Offers Halloween Deals for Families

Updated Category News Views 0

Halloween at Circus Circus: A New Spin on Family Fun Ah, Circus Circus Las Vegas. It's that place that’s managed to blend screaming kids, excited parents, and a flurry of flashing lights into something resembling an amusement park—on the Strip no less. Now, they're turning up the heat for Halloween. Yup, they're rolling out half-price Midway games and Adventuredome...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Soaring Growth of the Graphene Market Ahead

Updated Category News Views 264

Understanding the Growth of the Graphene Market The Graphene market is witnessing a remarkable journey, with projections suggesting it could reach an astounding USD 4,997.1 million by 2032. This growth represents a captivating compound annual growth rate (CAGR) of 33.2% from 2024 to 2032, highlighting the material's increasing application across diverse sectors such as...

Continue Reading
Volvo Group Navigates Q3 Market Challenges and Future Prospects

Updated Category News Views 124

Volvo Group's Third Quarter Summary Volvo Group (OTC: VLVLY, VOLV.B) has reported a challenging third quarter for 2024, characterized by normalization of demand in key segments. The company experienced a decline in net sales, recording SEK 170 billion, while adjusted operating income stood at SEK 14.1 billion with a 12% margin. These figures reflect the ongoing...

Continue Reading
Exploring the Future of Digital Security Control: A Growth Story

Updated Category News Views 337

Digital Security Control Market Overview The Digital Security Control Market is witnessing transformative growth, fueled by increasing cyber threats and the rising demand for sophisticated security solutions. By integrating technologies like artificial intelligence and machine learning, organizations are rethinking their approach to cybersecurity, adapting to the evolving...

Continue Reading
Carisma Therapeutics Set to Share Innovations at Key Conference

Updated Category News Views 127

Carisma Therapeutics to Share Insights at Annual Conference Carisma Therapeutics Inc. (NASDAQ: CARM), known for its innovative macrophage-focused therapies, is gearing up to make waves at an upcoming virtual event. This conference will allow the company to highlight its advancements in developing therapies aimed at combating significant health issues, including cancer and...

Continue Reading
XWELL, Inc.: Strong Third Quarter Performance and Future Outlook

Updated Category News Views 72

Overview of XWELL, Inc.'s Performance XWELL, Inc. (Nasdaq: XWEL), known for its innovative wellness solutions, has shown significant progress in its recent reports. The company has experienced a remarkable revenue growth of around 13% for the third quarter, compared to the same period last year. This uptick reflects a robust strategy towards sustainable profit recovery...

Continue Reading